Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course and Prognosis

ConditionsCOPD (Chronic Obstructive Pulmonary Disease)Heart Failure With Preserved Ejection Fraction (HFpEF; Diagnosis)

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age50-70

SponsorNational Medical Research Center for Therapy and Preventive Medicine

About this trial

Study aim is comparison of heart failire with preserved ejection fraction (HFpEF) detection rate in patients with Сhronic Obstructive Pulmonary Disease (COPD) and the clinical course and prognosis in patients with COPD depending on HFpEF presence.

Eligibility criteria

Qualifiers

Verified diagnosis of COPD;

Patients hospitalized with COPD;

Citizenship of the Russian Federation;

Patients aged 50 to 70 years;

Disqualifiers

Lack of Russian Federaion citizenship;

Patient's refusal to participate in the study;

Any chronic diseases, other than COPD, that affect the prognosis, in the acute and/or decompensated stage;

Mental disorders.

Trial design

Treatments tested in this trial

Echocardiography
Spirometry
Body plethysmography
6-Minute Walk Test (6MWT)
laboratory biomarker analysis

Treatment groups

200 Participants

are divided into 1 treatment group

Locations

Kazan State Medical University Kazan' Russia

National Medical Research Center for Therapy and Preventive Medicine Moscow Russia

Sponsors and collaborators

National Medical Research Center for Therapy and Preventive Medicine

Lead sponsor

Kazan State Medical University

Collaborator

Source ClinicalTrials.gov